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ABSTRAK
Latar belakang: lupus eritematosus sistemik (LES) merupakan penyakit autoimun kompleks yang membutuhkan 
penanganan khusus, terutama saat kehamilan. Kesadaran akan faktor-faktor yang menyebabkan luaran kehamilan 
yang buruk penting untuk optimalisasi luaran kehamilan pada pasien LES. Penelitian ini bertujuan memberikan 
gambaran mengenai luaran kehamilan dan faktor risiko yang berhubungan dengan buruknya luaran kehamilan 
pada pasien LES. Metode: penelitian kasus-kontrol retrospektif dilakukan pada pasien LES dengan berbagai 
luaran kehamilan. Riwayat dan komplikasi kehamilan diketahui dari data registri lupus di Rumah Sakit Umum 
Pusat Dr. Hasan Sadikin Bandung. Kelompok kasus berupa kehamilan dengan luaran yang buruk; yaitu aborsi, 
kelahiran prematur, lahir mati, pertumbuhan janin terhambat (PJT), dan kematian neonatal. Kelompok kontrol 
berupa kehamilan dengan luaran yang baik yakni lahir hidup dan cukup bulan. Hasil: Total 84 pasien LES terlibat 
di dalam penelitian ini dengan 109 data kehamilan setelah diagnosis LES. Median usia subjek pada saat kehamilan 
adalah 28 (25-32) tahun. Luaran kehamilan yang buruk terdiri dari 22,9% abortus, 14,7% kelahiran prematur, 
5,5% lahir mati, 1,8% PJT, dan 4,6% kematian neonatal. Kelompok kasus dan kontrol memiliki perbedaan yang 
bermakna dalam hal jumlah kehamilan terencana (P=0,011). Luaran  kehamilan yang buruk dalam penelitian ini 
berhubungan dengan lupus nefritis (OR = 4,813, 95% CI 1,709 – 13,557, P = 0,003) dan SLE neuropsikiatri (OR 
= 5,045, 95% CI 1,278 – 19,920, P = 0,021). Kesimpulan: perencanaan kehamilan diperlukan untuk mendapatkan 
luaran kehamilan yang lebih baik. Nefritis dan neuropsikiatri lupus merupakan faktor risiko bagi terjadinya luaran 
kehamilan  yang buruk.
Kata kunci:  lupus eritematosus sistemik, kehamilan, luaran buruk.
ABSTRACT
Background: systemic lupus erythematosus (SLE) is still a challenging autoimmune disease, especially in 
pregnancy setting. An early risk factors awareness of poor pregnancy outcome is important to optimize the outcome 
of pregnancy in SLE patients. This study was conducted to describe pregnancy outcome and determine the risk 
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factors associated with poor pregnancy outcome in SLE patients. Methods: a retrospective case-control study of 
SLE patients with poor and normal pregnancy outcome was performed. Pregnancy histories were reviewed from Dr. 
Hasan Sadikin General Hospital lupus registry study. The case group was pregnancy with poor outcome, defined 
as abortion, premature birth, stillbirth, intrauterine growth restriction (IUGR) and neonatal death. The control 
group was pregnancy with good outcome, defined as live birth and full term. Results: a total of 84 SLE patients 
were enrolled in this study with 109 pregnancies after SLE diagnosis. The median age of subjects at the time of 
pregnancy was 28 (25-32) years old. Poor pregnancy outcome comprising 22.9% abortion, 14.7% premature 
birth, 5.5% stillbirth, 1.8% IUGR and 4.6% neonatal death. There was a significant difference in the number 
of planned pregnancy (P=0.011) between groups with poor and good outcome. Clinical variables significantly 
associated with poor pregnancy outcome were lupus nephritis (OR = 4.813, 95% CI 1.709 – 13.557, P = 0.003) 
and neuropsychiatric SLE (OR = 5.045, 95% CI 1.278 – 19.920, P = 0.021). Conclusion: the pregnancy in SLE 
patient should be planned to have better outcome. Lupus nephritis and neuropsychiatric (NP) SLE were risk factors 
for poor pregnancy outcome in SLE patient.
Keywords:  systemic lupus erythematosus; pregnancy; poor outcome.
INTRODUCTION
Systemic lupus erythematosus (SLE) is 
a multi-organ autoimmune disease which 
commonly occurrs during childbearing age.1–5 
Improved treatment in SLE carried better quality 
of life and allowed pregnancies in SLE patient, 
yet the pregnancy outcome is still unfavorable. 
Pregnancy in women with SLE have a higher 
maternal and fetal risk compared with pregnancy 
in healthy women.6–8 Maternal complications 
include lupus flare, hypertension, nephritis, 
preeclampsia, and eclampsia, while poor 
pregnancy outcomes include preterm delivery, 
pregnancy loss, and intra-uterine growth 
restriction (IUGR).9,10 The predictors of adverse 
pregnancy outcome include maternal age above 
35 years old, active maternal disease, nephritis, 
proteinuria, hypertension, thrombocytopenia, 
and presence of anti-phospholipid antibodies, 
especially lupus anticoagulant.6,11,12 Clowse ME 
et al.11 study showed that pregnancy loss was 
increased 2.6 and 3.3 times in first-trimester 
women with proteinuria and thrombocytopenia 
consecutively. High-activity lupus led to a 6-fold 
increase in fetal loss.13  In a pregnant SLE patient, 
renal involvement known as lupus nephritis is a 
common feature. The rate of pregnancy loss in 
patients with active nephritis was reported to be 
as high as 12 to 38%.14
Disease activity at the time of conception is 
an indicator of pregnancy outcomes, and high 
activity leads to poor outcomes.6 Improving 
pregnancy outcome in SLE patients could 
be achieved with good pregnancy plan. 
Consequently, an awareness of risk factors 
for poor pregnancy outcome is important. The 
purpose of this study is to describe pregnancy 
outcome and determine the risk factors associated 
with poor pregnancy outcome in SLE.
METHODS
A retrospective case-control study was 
conducted by retrieving complete medical 
records of female SLE patients who have been 
registered in Dr. Hasan Sadikin General Hospital 
Bandung lupus registry from September 2016 
to January 2018. We conducted this study from 
January 2018 to March 2018. Minimal sample 
size was calculated using rule of thumb method 
for five variable risk factors analysis. Subjects 
in case group were collected by consecutive 
sampling method within certain time duration, 
and subjects in control group were matched to 
the case group based on age at pregnancy, SLE 
duration, gravidity and parity status. These SLE 
patients fulfilled at least four of eleven criteria for 
the classification of SLE from the 1997 American 
College of Rheumatology (ACR) revised criteria 
for the classification of SLE.15 SLE patients who 
once had pregnancy after SLE diagnosis were 
enrolled in this study. Patients with incomplete 
data were excluded. Variable recorded data 
included the patients’ age at SLE diagnosis, 
the patients’ age at pregnancy, SLE disease 
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duration, and the frequency of pregnancy after 
SLE diagnosis. These variables were matched to 
find the difference between groups with poor and 
good outcome. A poor pregnancy outcome group 
was defined as pregnancies with abortion (loss of 
fetal <20 weeks), premature birth (termination 
of pregnancy with a live birth between weeks 
21 and 37)16, stillbirth (a fetal death that occurs 
during pregnancy ≥20 weeks)17, intrauterine 
growth restriction/ IUGR (estimated fetal weight 
that is less than the 10th percentile for gestational 
age)18, and neonatal death. Good pregnancy 
outcome group was pregnancies with live birth 
and full-term birth (termination of pregnancy with 
a live birth between 38 and 42 weeks)19 in SLE 
patients. Furthermore, several complications of 
SLE consisting of lupus nephritis, hypertension 
(based on European Society of Hypertension/
European Society of Cardiology guidelines)20, 
thrombocytopenia (platelet levels below 105 cells/
uL for two times, unrelated to drugs usage), and 
neuropsychiatric SLE (NPSLE) (based on ACR 
neuropsychiatric SLE nomenclature)21 were also 
evaluated for their effects to pregnancy outcome. 
Lupus nephritis is defined based on WHO lupus 
nephritis criteria, class III-V.22 Furthermore, 
planned pregnancy is defined as pregnancy 
in minimum of six months remission of SLE 
disease activity and medically monitored at least 
monthly.23
Data were analyzed with STATA 14.0 
statistical software. Descriptive analyses included 
mean (SD)/median (Q1-Q3) for continuous 
numerical outcomes and percentage frequency 
distribution for categorical data. Homogeneity of 
baseline pregnancy characteristics between case 
and control groups such as age at pregnancy, SLE 
duration, planned pregnancy, multigravida, and 
multipara were evaluated using Mann–Whitney 
U and Chi-square tests. Maternal complication 
characteristics were compared their occurrence 
between two groups using Chi-square and 
Fisher’s exact tests. All P-values <0.05 were 
considered statistically significant. Multivariate 
analysis was performed included five variables 
(maternal age, lupus nephritis, hypertension, 
thrombocytopenia, neuropsychiatric SLE) 
with P-values <0.25 in bivariate analysis. We 
considered a higher P-value because a traditional 
levels (0.05) can fail in identifying variables 
known to be important.24 Multivariate analysis 
was performed with logistic regression analysis 
and backward stepwise process. Odds ratios 
(OR) >1, falling within the 95% confidence 
interval were significant correlates. All P-values 
<0.05 were considered statistically significant.
This is a part of the lupus registry study at 
Dr. Hasan Sadikin General Hospital Bandung, 
which has been approved by the Institutional 
ethic committee on January 2nd, 2018, reference 
number 01/UN6.C.10/PN/2018. Written 
informed consent was obtained from each 
participant in the lupus registry.
RESULTS
A total of 84 SLE patients evaluated in this 
study with 109 pregnancies after SLE diagnosis. 
The median age of subjects at the time of 
pregnancy was 28 (25-32) years old. Twenty 
(23.8%) of subjects had low levels of education 
(below or equal junior high school).25 Maternal 
death was one of the complications of pregnancy; 
Table 1. General characteristics of subjects
Variables n (%)
Age at SLE diagnosis (years), n=84, 
Mean (SD) 26 (6)
Low levels of education 20 (23.8)
Multigravida 31 (36.9)
Multipara 22 (26.2)
Amount of pregnancy after diagnosis
 - 1 63 (75.0)
 - 2 17 (20.2)
 - 3 3 (3.6)
 - 4 1 (1.2)
Maternal death 2 (2.4)
Poor pregnancy outcome (n=109)
 - Spontaneous abortion 19 (17.4)
 - Induced abortion 6 (5.5)
 - Premature birth (20 -37 Weeks) 16 (14.7)
 - Stillbirth 6 (5.5)
 - Intrauterine growth restriction (IUGR) 1 (0.9)
 - Neonatal death 4 (3.7)
 - Full term birth (38-42 weeks) 0 (0.0)
 - Stillbirth 0 (0.0)
 - Intrauterine growth restriction (IUGR) 1 (0.9)
 - Neonatal death 1 (0.9)
Full term and live birth 55 (50.5)
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our study showed 2 (2.4%) mothers died after 
delivering their babies due to active lupus disease 
and concomitant infection. (Table 1)
Abortion (22.9%) was the most common 
adverse outcome of pregnancy, including 
induced abortion (5.5%) in case of blighted 
ovum, missed abortion, mother’s life threatening 
condition and spontaneous abortion (17.4%), 
followed by premature birth (14.7%) (Table 1). 
Only 21.1% pregnancies were planned before 
conception, with 73.9% of planned pregnancies 
leading to good pregnancy outcome. There was 
a significant difference between the number of 
planned pregnancy (P= 0.011) in poor outcome 
and control group (Table 2).
Multivariate analysis of independent factors 
associated with poor pregnancy outcome was done 
by using logistic regression analysis. The effects of 
lupus nephritis, hypertension, thrombocytopenia, 
and neuropsychiatric SLE (predictor variables with 
P-value <0.25 in bivariate analysis) to pregnancy 
outcome were examined with multivariate 
analysis. Lupus nephritis (OR = 4.813, 95% CI 
1.709 – 13.557, P = 0.003) and neuropsychiatric 
SLE (OR = 5.045, 95% CI 1.278 – 19.920, P = 
0.021) were predictors of poor outcome in SLE 
patients (Table 3).
Based on multivariate logistic regression 
analysis, the probability of poor pregnancy 
outcome in patients with lupus nephritis and 
Table 2. Baseline characteristic comparison of pregnancy outcome in SLE patients
All pregnancies 
(n=109)




Age at pregnancy (years)
Median (Q1 - Q3) 28 (25-32) 28 (24 - 33) 28 (26 - 31) 0.721a
SLE duration (months)
Median (Q1- Q3) 30 (10-66) 24 (10 – 50) 35 (10 – 73) 0.243a
Maternal age >35 years, n (%) 13 (11.9) 8 (14.8) 5 (9.1) 0.357 b
Multigravida, n (%) 33  (30.2) 19 (35.2) 14 (25.4) 0.269b
Multipara, n (%) 27 (24.7) 13 (24.1) 14 (25.4) 0.867b
Planned pregnancy, n (%) 23 (21.1) 6 (11.1) 17 (30.9) 0.011b*
Maternal complication
 - Rash, n (%) 20 (18.3) 10 (18.5) 10 (18.2) 0.964b
 - Arthritis, n (%) 34 (31.2) 15 (27.8) 19 (34.5) 0.446b
 - Preeclampsia, n (%) 17 (15.6) 8 (14.8) 9 (16.3) 0.824b
 - Lupus nephritis, n (%) 25 (22.9) 19 (35.2) 6 (10.9) 0.003b*
 - Hypertension, n (%) 18 (16.5) 14 (25.9) 4 (7.3) 0.010c*
 - Thrombocytopenia, n (%) 15 (13.7) 11 (20.4) 4 (7.3) 0.056c
 - Neuropsychiatric SLE, n (%) 14 (12.8) 11 (20.4) 3 (5.4) 0.024c*
*P-value <0.05. Data were analyzed with  aMann Whitney –U test, bChi-square test, cFisher’s exact test
Table 3. Multivariate logistic regression analysis of risk factors for poor pregnancy outcome in SLE patients 
Risk factors
Univariate Logistic Regression Multivariate Logistic Regression
Crude OR (95% CI) P-value Adjusted OR (95% CI) P-value
Lupus nephritis 4.433 (1.606–12.253) 0.004* 4.813 (1.709– 13.557) 0.003*
Hypertension 4.462 (1.363–14.607) 0.013*
Thrombocytopenia 3.262 (0.969–10.984)  0.056
Neuropsychiatric SLE 4.434 (1.162–16.917) 0.029* 5.045 (1.278 – 19.920) 0.021*
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NPSLE is 0.934. However, if a patient has only 
one of risk factors; lupus nephritis or NPSLE, 
the probabilities are 0.736 and 0.745 respectively 
(Figure 1).
Maternal Outcome
SLE flare is commonly induced by pregnancy 
in SLE patients. In this study, the most common 
maternal complications were arthritis (31.2%) 
and lupus nephritis (22.9%), followed by rash 
(18.3%), hypertension (16.5%), preeclampsia 
(15.6%), thrombocytopenia (13.7%), and 
neuropsychiatric SLE (12.8%). Maternal death 
occurred in 2.4% of SLE patients. Similarly, a 
meta-analysis of 37 studies reported the most 
frequent maternal complications, including lupus 
flare (25.6%), hypertension (16.3%), nephritis 
(16.1%), and pre-eclampsia (7.6%) with severe 
complications (eclampsia, stroke, and maternal 
death), were observed in 1% of subjects.9 In 
Thailand, Foocharoen et al.29 demonstrated that 
lupus nephritis, hemolytic anemia, cutaneous 
rash, and arthritis were the most common 
manifestations during pregnancy.
Pregnancy Outcome
In this study, the adverse pregnancy outcome 
included abortion (22.9%), premature birth 
(14.7%), stillbirth (5.5%), IUGR (1.8%), and 
neonatal death (4.6%). Compared with previous 
studies, we have higher abortion (21.9%), 
stillbirth (3.6%), neonatal death (2.5%), and 
lower premature birth (39.4%) and intrauterine 
growth retardation (12.7%).9 Another studies 
even showed 10 to 30 percent of pregnancies in 
women with SLE are complicated by fetal growth 
restriction.6 The poor pregnancy outcome in our 
center might be caused by several conditions. 
Firstly, our center was a tertiary hospital, dealing 
with more complicated cases. Secondly, there 
was a high number of unplanned pregnancy 
(78.9%). Pregnancies should be delayed until 
the disease has been in remission for 6 months.30
Regression analysis showed that lupus 
nephritis and neuropsychiatric SLE were 
two predictors of poor pregnancy outcome 
in this study. Lupus nephritis might cause 
microcirculation impairment of uteroplacental 
vessels.33 Nephritis history is known to have 
been associated with pre-eclampsia.9 Pregnancies 
in active lupus nephritis were associated with 
higher rates of maternal complications (57% 
vs. 11%) and fetal loss (35% vs 9%) compared 
those without renal involvement.12 Women with 
lupus nephritis were reported to have 39.4% 


















Our subject’s age characteristic was similar as 
several studies in China, Thailand, South Korea 
and Saudi Arabia but with shorter SLE disease 
duration.26–29 This disease duration difference 
might carry different clinical presentation and 
pregnancy outcome.
We demonstrated significant difference of 
the number of planned pregnancy in pregnancy 
outcome; with 73.9% of planned pregnancies 
leading to good pregnancy outcome. The 
timing of conception is an important aspect of 
pregnancy outcome. Kwok et al.30 found that 
a history of nephritis or active lupus disease 
in SLE patients six months before conception 
predicts adverse fetal outcomes. Contrary to 
unplanned pregnancies, fetal survival rate 
could reach 87.9% in planned pregnancies.23 
Another observational study which included 385 
pregnant lupus patients with inactive or mild/
moderate disease at conception, demonstrated 
uncomplicated pregnancies in 81% of subjects.31
Immunological adaptations in the pregnant 
setting of SLE patients lead to high risk of 
adverse pregnancy outcomes in both the mother 
and the baby.32 Al Arfaj et al.28 found that live 
births were significantly fewer (70.2% vs. 
85.7%) and more frequently to end in fetal deaths 
(29.7% vs. 14.2%), and preterm births (26.7% vs. 
5.8 %) in pregnancies occurring after SLE onset 
than in pregnancies occurring before SLE onset.
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rates of premature birth.9 Furthermore, patients 
with neuropsychiatric SLE had 5.0 times higher 
risk of poor pregnancy outcome. They had a 
higher rate of prematurity and preeclampsia 
compared with patients without neuropsychiatric 
disease.34 El-Sayed et al.35 also found extreme 
prematurity and neonatal death in the central 
nervous system (CNS) of Lupus patient. It was 
found an association of neuropsychiatric with 
antiphospholipid syndrome (APS), especially 
arterial thrombotic events.36 Antiphospholipid 
syndrome is associated with an increased risk 
of preeclampsia, IUGR, and other complications 
related to uteroplacental insufficiency.37  However, 
de Jesus et al.34, did not find any association 
between neuropsychiatric SLE and APS. There 
was only a limited study with very few subjects 
on neuropsychiatric SLE with pregnancy. One 
study even found that when other concomitant 
risk factors are excluded, the pregnancy outcome 
becomes more favorable.34
Findings from this study suggest that 
patients with a history of hypertension have 
an increased risk of poor pregnancy outcome 
although the association was not significant 
in multivariable analysis. Consistent with 
previous study, hypertension increases the risk 
of premature deliveries and IUGR 15.7 and 37.7 
times respectively.28 Hypertension in pregnancy 
was found to be associated with prematurity and 
IUGR by impairing uteroplacental perfusion.28,38
However, thrombocytopenia did not 
significantly cause poor pregnancy outcome. This 
result is contrary to two studies in Chinese women 
which found that the rate of thrombocytopenia 
significantly increased in patients with fetal 
loss.39,40 The difference in thrombocytopenia 
definition might explain this finding. It could 
be noted that these predictor factors might not 
cause poor pregnancy outcome directly but they 
were only representation of SLE disease severity. 
This was the first study in Indonesia 
evaluating risk factors and their probabilites for 
poor pregnancy outcome in SLE patients. There 
were several limitations in this study. We did not 
include some risk factors, such as SLE disease 
activity, antiphospholipid syndrome, history 
of thrombosis and anti-Ro/SSA antibodies 
due to data unavailability. The diagnosis of 
lupus nephritis in this study was not based on 
histopathologic examination due to the fact that 
none of the patients performed kidney biopsy. 
The effect of SLE medication to pregnancy 
outcome was also not evaluated. Finally, this 
study emphasized the importance of the right 
conception timing to optimize pregnancy. In 
order to be succesful in this action, the guideline 
for SLE pregnancy planning and termination 
should be routinely implemented.
CONCLUSION
The pregnancy in SLE patient should be 
planned to have better outcome. Lupus nephritis 
and neuropsychiatric SLE were risk factors for 
poor pregnancy outcome in SLE patient.
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